These Stocks Are Today's Movers: Wells Fargo, JPMorgan, BlackRock, American, Credo, CarMax, J&J, and More -- Barrons.com

Dow Jones
04/14

By Mackenzie Tatananni and George Glover

Stock futures were mostly higher Tuesday as investors gathered hope for a peace deal between the U.S. and Iran and big banks ushered in the earnings season.

These stocks were poised to make moves:

Wells Fargo fell 2%. First-quarter net interest income came to $12.1 billion, missing analysts' forecasts for $12.3 billion and marking a 2% decline from the previous quarter.

JPMorgan Chase slipped 0.8%. The bank's first-quarter profit rose 13% to $16.5 billion, or $5.94 on a per-share basis, better than Wall Street's calls for $5.45. Revenue of $49.8 billion also topped estimates.

BlackRock gained 2.4%. The world's largest asset manager reported $2.2 billion in net income, marking a 46% jump from the same period last year. A record first quarter for BlackRock's iShares exchange-traded fund business contributed to $130 billion in net inflows.

Bloom Energy surged 15% on the heels of a deal announcement with Oracle to support the buildout of the latter's artificial-intelligence and cloud computing infrastructure. Oracle stock rose 3.6% and looked set to add to its gains from the previous session, where it closed up 13%.

CarMax tumbled 6.8%. The used-car dealer posted another year-over-year drop in quarterly earnings and revenue. CarMax recorded a $141.3 million goodwill impairment charge during the fiscal fourth quarter, driven by its falling stock price and weak financial performance.

Novo Nordisk gained 3.1% in the U.S. after the Danish drugmaker unveiled a partnership with OpenAI. Novo said it plans to use AI in drug discovery and supply chain improvements, and is targeting full integration by the end of the year.

Johnson & Johnson was down 1.5% even after first-quarter earnings and sales beat expectations. While sales of Stelara, J&J's former blockbuster, continued to decline, multiple myeloma treatment Darzalex and anti-inflammatory medicine Tremfya drove strength in the company's Innovative Medicines portfolio.

Credo Technology Group jumped 16% after the electrical cable provider said it would buy chip maker DustPhotonics as it bids to become the dominant player in AI connectivity.

Intel advanced 0.9%, putting the chip maker on course to extend its winning streak to 10 sessions. Shares have jumped 58% over the past nine trading days, rallying thanks to collaborations with Tesla and Alphabet's Google, and Intel buying back full control of its chip factory in Ireland.

American Airlines and United Airlines added 7.8% and 2.9%, respectively, after Bloomberg reported that United CEO Scott Kirby had pitched a potential combination between the two carriers. The outlet cited people familiar with the matter.

Globalstar was up 0.9% following a report that Amazon was in talks to acquire the satellite operator, with a deal announced as soon as Tuesday. Globalstar and Amazon didn't immediately respond to requests for comment.

Write to Mackenzie Tatananni at mackenzie.tatananni@barrons.com and George Glover at george.glover@dowjones.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

April 14, 2026 07:45 ET (11:45 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10